A Phase 3 Study of Efficacy and Safety of AK101 in Subjects With Psoriasis

NCT05120297 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
452
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Akeso